{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:35:15Z","timestamp":1790771715130,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100282"],"award-info":[{"award-number":["82100282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1.3.5 project for disciplines of excellence\u2013Clinical Research Incubation Project, West China Hospital, Sichuan University","award":["2021HXFH021"],"award-info":[{"award-number":["2021HXFH021"]}]},{"name":"The Science & Technology Pillar Program of Sichuan Province","award":["2022YFS0357"],"award-info":[{"award-number":["2022YFS0357"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10557-025-07676-3","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T06:16:29Z","timestamp":1738736189000},"page":"191-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety Analysis of Spironolactone Use in Patients Undergoing Percutaneous Coronary Intervention with High Bleeding Risk: A Propensity Score-Matched Study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2448-9598","authenticated-orcid":false,"given":"Junyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"7676_CR1","doi-asserted-by":"publisher","unstructured":"Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J ehad191. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"7676_CR2","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","volume":"75","author":"D Cao","year":"2020","unstructured":"Cao D, Mehran R, Dangas G, et al. Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients. J Am Coll Cardiol. 2020;75:2711\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.070.","journal-title":"J Am Coll Cardiol"},{"key":"7676_CR3","doi-asserted-by":"publisher","first-page":"e008307","DOI":"10.1161\/CIRCINTERVENTIONS.119.008307","volume":"12","author":"M Natsuaki","year":"2019","unstructured":"Natsuaki M, Morimoto T, Shiomi H, et al. Application of the academic research consortium high bleeding risk criteria in an All-Comers Registry of Percutaneous Coronary Intervention. Circ: Cardiovasc Interv. 2019;12:e008307. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.119.008307.","journal-title":"Circ: Cardiovasc Interv"},{"key":"7676_CR4","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","volume":"41","author":"N Corpataux","year":"2020","unstructured":"Corpataux N, Spirito A, Gragnano F, et al. Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk. Eur Heart J. 2020;41:3743\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa671.","journal-title":"Eur Heart J"},{"key":"7676_CR5","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/jama.2020.16167","volume":"324","author":"SC You","year":"2020","unstructured":"You SC, Rho Y, Bikdeli B, et al. Association of Ticagrelor vs Clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA. 2020;324:1640\u201350. https:\/\/doi.org\/10.1001\/jama.2020.16167.","journal-title":"JAMA"},{"key":"7676_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.amjcard.2005.03.038","volume":"96","author":"AE Abbas","year":"2005","unstructured":"Abbas AE, Brodie B, Dixon S, et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2005;96:173\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2005.03.038.","journal-title":"Am J Cardiol"},{"key":"7676_CR7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jacc.2009.07.019","volume":"54","author":"E Nikolsky","year":"2009","unstructured":"Nikolsky E, Stone GW, Kirtane AJ, et al. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009;54:1293\u2013302. https:\/\/doi.org\/10.1016\/j.jacc.2009.07.019.","journal-title":"J Am Coll Cardiol"},{"key":"7676_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jacc.2015.01.047","volume":"65","author":"DS Kazi","year":"2015","unstructured":"Kazi DS, Leong TK, Chang TI, et al. Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2015;65:1411\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.047.","journal-title":"J Am Coll Cardiol"},{"key":"7676_CR9","doi-asserted-by":"publisher","first-page":"e001645","DOI":"10.1161\/CIRCINTERVENTIONS.114.001645","volume":"8","author":"CS Kwok","year":"2015","unstructured":"Kwok CS, Khan MA, Rao SV, et al. Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis. Circ Cardiovasc Interv. 2015;8:e001645. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.114.001645.","journal-title":"Circ Cardiovasc Interv"},{"key":"7676_CR10","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","volume":"40","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J. 2019;40:2632\u201353. https:\/\/doi.org\/10.1093\/eurheartj\/ehz372.","journal-title":"Eur Heart J"},{"key":"7676_CR11","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"key":"7676_CR12","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44:3627\u201339. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195.","journal-title":"Eur Heart J"},{"key":"7676_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/bmj.38883.479549.2F","volume":"333","author":"K Verhamme","year":"2006","unstructured":"Verhamme K, Mosis G, Dieleman J, et al. Spironolactone and risk of upper gastrointestinal events: population based case-control study. BMJ. 2006;333:330. https:\/\/doi.org\/10.1136\/bmj.38883.479549.2F.","journal-title":"BMJ"},{"key":"7676_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2125.2008.03205.x","volume":"66","author":"SE Gulmez","year":"2008","unstructured":"Gulmez SE, Lassen AT, Aalykke C, et al. Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study. Br J Clin Pharmacol. 2008;66:294\u20139. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03205.x.","journal-title":"Br J Clin Pharmacol"},{"key":"7676_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/pds.1583","volume":"17","author":"A Russo","year":"2008","unstructured":"Russo A, Autelitano M, Bisanti L. Spironolactone and gastrointestinal bleeding: a population based study. Pharmacoepidemiol Drug Saf. 2008;17:495\u2013500. https:\/\/doi.org\/10.1002\/pds.1583.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"7676_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/bmj.333.7566.501","volume":"333","author":"MF Dawwas","year":"2006","unstructured":"Dawwas MF. Spironolactone and risk of upper gastrointestinal events: association is unproved. BMJ. 2006;333:501. https:\/\/doi.org\/10.1136\/bmj.333.7566.501.","journal-title":"BMJ"},{"key":"7676_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/bmj.333.7566.501-a","volume":"333","author":"GP Jones","year":"2006","unstructured":"Jones GP. Spironolactone and risk of upper gastrointestinal events: causality remains unconvincing. BMJ. 2006;333:501. https:\/\/doi.org\/10.1136\/bmj.333.7566.501-a.","journal-title":"BMJ"},{"key":"7676_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","volume":"11","author":"GN Levine","year":"2014","unstructured":"Levine GN, Jeong Y-H, Goto S, et al. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014;11:597\u2013606. https:\/\/doi.org\/10.1038\/nrcardio.2014.104.","journal-title":"Nat Rev Cardiol"},{"key":"7676_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0040-1718729","volume":"121","author":"HK Kim","year":"2021","unstructured":"Kim HK, Tantry US, Smith SC, et al. The East Asian Paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost. 2021;121:422\u201332. https:\/\/doi.org\/10.1055\/s-0040-1718729.","journal-title":"Thromb Haemost"},{"key":"7676_CR20","doi-asserted-by":"publisher","unstructured":"Zhang J, Chen Z, Wang H, et al. Prognostic analysis and an appropriate antiplatelet strategy for patients with percutaneous coronary intervention and high bleeding risk: rationale and protocol for a multi-center cohort study. Cardiol Discov. https:\/\/doi.org\/10.1097\/CD9.0000000000000121","DOI":"10.1097\/CD9.0000000000000121"},{"key":"7676_CR21","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.009449.","journal-title":"Circulation"},{"key":"7676_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"D Ho","year":"2011","unstructured":"Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42:1\u201328. https:\/\/doi.org\/10.18637\/jss.v042.i08.","journal-title":"J Stat Softw."},{"key":"7676_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/bmj.333.7566.500-c","volume":"333","author":"E Campbell","year":"2006","unstructured":"Campbell E, Shonde A, Foley S. Spironolactone and risk of upper gastrointestinal events: spironolactone may not be guilty. BMJ. 2006;333:500\u20131. https:\/\/doi.org\/10.1136\/bmj.333.7566.500-c.","journal-title":"BMJ."},{"key":"7676_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/gut.9.1.42","volume":"9","author":"R Doll","year":"1968","unstructured":"Doll R, Langman MJ, Shawdon HH. Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone. Gut. 1968;9:42\u20135. https:\/\/doi.org\/10.1136\/gut.9.1.42.","journal-title":"Gut"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07676-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:58:37Z","timestamp":1770202717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07676-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7676"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07676-3","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"19 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of West China Hospital (No. 2022\u2013269) and all patients provided informed consent for the procedure as well as the subsequent data collection and analysis for research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from all participating patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have read and approved the final manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}